| Dr Kayla Blanek, DDS | |
|
12736 Bass Lake Rd, Maple Grove, MN 55369-6307 | |
| (763) 559-2082 | |
| Not Available |
| Full Name | Dr Kayla Blanek |
|---|---|
| Gender | Female |
| Speciality | Dentist - General Practice |
| Location | 12736 Bass Lake Rd, Maple Grove, Minnesota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134807134 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | D14881 (Minnesota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kayla Blanek, DDS 1538 E 54th St, Minneapolis, MN 55417-1818 Ph: (952) 446-5589 | Dr Kayla Blanek, DDS 12736 Bass Lake Rd, Maple Grove, MN 55369-6307 Ph: (763) 559-2082 |
News Archive
Entellus Medical, the Minnesota-based developer of novel, less invasive treatments for chronic conditions of sinusitis, has completed its Series D financing totaling $30MM. The Series D round was led by new investor Essex Woodlands Health Ventures and supported by existing investors Split Rock Partners and SV Life Sciences.
On July 29, 2010 the International Society for Medical Publication Professionals (ISMPP) and the Medical Publishing Insights and Practices (MPIP) initiative launched a new web page highlighting various MPIP initiatives (http://www.mpip-initiative.org). The web page is a valuable resource providing information on the overall MPIP initiative, updating viewers on new or planned activities, and providing access to previous MPIP publications and resources.
Goodwin Biotechnology, Inc., a biological Contract Development and Manufacturing Organization that specializes in bioprocess development and GMP manufacturing of biopharmaceuticals utilizing Mammalian Cell Culture expression systems and Bioconjugation technologies, was selected by Panacea Pharmaceuticals, Inc. to complete a novel Fill / Finish project, as well as Quality Control release and stability testing for a therapeutic, nanoparticle cancer vaccine based on the Human Aspartyl (Asparaginyl) β-Hydroxylase (HAAH) tumor-specific protein to support Phase I clinical trials in patients with various solid tumor cancers.
GlaxoSmithKline has welcomed the nearly unanimous recommendation of an U.S. Food and Drug Administration's (FDA) advisory committee to support Avandia's (rosiglitazone maleate) continued availability to patients in the U.S.
› Verified 1 days ago
Hannah Moran, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 10182 Lancaster Ln N, Maple Grove, MN 55369 Phone: 773-384-3500 | |
Dr. Richard William Topel, DDS Dentist Medicare: Medicare Enrolled Practice Location: 12736 Bass Lake Rd, Maple Grove, MN 55369 Phone: 763-559-2082 | |
Dr. Paul M Hobday, DDS, MS Dentist Medicare: Not Enrolled in Medicare Practice Location: 6810 Hemlock Ln N, Maple Grove, MN 55369 Phone: 763-425-9888 Fax: 763-425-9835 | |
Dr. James Michael Healy, DDS Dentist Medicare: Medicare Enrolled Practice Location: 15785 95th Ave N, Maple Grove, MN 55369 Phone: 763-420-5484 Fax: 763-420-5875 | |
Dr. Scott Kottemann, Dentist Medicare: Not Enrolled in Medicare Practice Location: 13998 Maple Knoll Way, Suite 102, Maple Grove, MN 55369 Phone: 763-420-6834 | |
Jonathan Gee Hin Wong, Dentist Medicare: Not Enrolled in Medicare Practice Location: 7200 Hemlock Ln N Ste 105, Maple Grove, MN 55369 Phone: 763-424-4415 | |
Dr. Shruti Jagannathan, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 11301 Fountains Dr, Maple Grove, MN 55369 Phone: 763-762-7177 |